Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury

Ahmed Bettaieb, Shinichiro Koike, Samah Chahed, Yi Zhao, Santana Bachaalany, Nader Hashoush, James Graham, Huma Fatima, Peter J Havel, Artiom Gruzdev, Darryl C. Zeldin, Bruce D. Hammock, Fawaz Haj

Research output: Contribution to journalEditorial

11 Citations (Scopus)

Abstract

Podocytes play an important role in maintaining glomerular function, and podocyte injury is a significant component in the pathogenesis of proteinuria. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose genetic deficiency and pharmacological inhibition have beneficial effects on renal function, but its role in podocytes remains unexplored. The objective of this study was to investigate the contribution of sEH in podocytes to lipopolysaccharide (LPS)-induced kidney injury. We report increased sEH transcript and protein expression in murine podocytes upon LPS challenge. To determine the function of sEH in podocytes in vivo we generated podocyte-specific sEH-deficient (pod-sEHKO) mice. Following LPS challenge, podocyte sEH-deficient mice exhibited lower kidney injury, proteinuria, and blood urea nitrogen concentrations than controls suggestive of preserved renal function. Also, renal mRNA and serum concentrations of inflammatory cytokines IL-6, IL-1β, and TNFα were significantly lower in LPS-treated pod-sEHKO than control mice. Moreover, podocyte sEH deficiency was associated with decreased LPS-induced NF-κB and MAPK activation and attenuated endoplasmic reticulum stress. Furthermore, the protective effects of podocyte sEH deficiency in vivo were recapitulated in E11 murine podocytes treated with a selective sEH pharmacological inhibitor. Altogether, these findings identify sEH in podocytes as a contributor to signaling events in acute renal injury and suggest that sEH inhibition may be of therapeutic value in proteinuria. Enzymes: Soluble epoxide hydrolase: EC 3.3.2.10.

Original languageEnglish (US)
Pages (from-to)1970-1986
Number of pages17
JournalFEBS Journal
Volume284
Issue number13
DOIs
StatePublished - Jul 1 2017

Fingerprint

Epoxide Hydrolases
Podocytes
Acute Kidney Injury
Lipopolysaccharides
Kidney
Proteinuria
Wounds and Injuries
Pharmacology
Endoplasmic Reticulum Stress
Blood Urea Nitrogen
Enzymes
Interleukin-1
Urea
Interleukin-6
Blood
Nitrogen

Keywords

  • knockout mice
  • podocyte
  • proteinuria
  • soluble epoxide hydrolase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Bettaieb, A., Koike, S., Chahed, S., Zhao, Y., Bachaalany, S., Hashoush, N., ... Haj, F. (2017). Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS Journal, 284(13), 1970-1986. https://doi.org/10.1111/febs.14100

Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. / Bettaieb, Ahmed; Koike, Shinichiro; Chahed, Samah; Zhao, Yi; Bachaalany, Santana; Hashoush, Nader; Graham, James; Fatima, Huma; Havel, Peter J; Gruzdev, Artiom; Zeldin, Darryl C.; Hammock, Bruce D.; Haj, Fawaz.

In: FEBS Journal, Vol. 284, No. 13, 01.07.2017, p. 1970-1986.

Research output: Contribution to journalEditorial

Bettaieb, A, Koike, S, Chahed, S, Zhao, Y, Bachaalany, S, Hashoush, N, Graham, J, Fatima, H, Havel, PJ, Gruzdev, A, Zeldin, DC, Hammock, BD & Haj, F 2017, 'Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury', FEBS Journal, vol. 284, no. 13, pp. 1970-1986. https://doi.org/10.1111/febs.14100
Bettaieb A, Koike S, Chahed S, Zhao Y, Bachaalany S, Hashoush N et al. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS Journal. 2017 Jul 1;284(13):1970-1986. https://doi.org/10.1111/febs.14100
Bettaieb, Ahmed ; Koike, Shinichiro ; Chahed, Samah ; Zhao, Yi ; Bachaalany, Santana ; Hashoush, Nader ; Graham, James ; Fatima, Huma ; Havel, Peter J ; Gruzdev, Artiom ; Zeldin, Darryl C. ; Hammock, Bruce D. ; Haj, Fawaz. / Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. In: FEBS Journal. 2017 ; Vol. 284, No. 13. pp. 1970-1986.
@article{3b872364a77d47eeafe4eedf59fe907d,
title = "Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury",
abstract = "Podocytes play an important role in maintaining glomerular function, and podocyte injury is a significant component in the pathogenesis of proteinuria. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose genetic deficiency and pharmacological inhibition have beneficial effects on renal function, but its role in podocytes remains unexplored. The objective of this study was to investigate the contribution of sEH in podocytes to lipopolysaccharide (LPS)-induced kidney injury. We report increased sEH transcript and protein expression in murine podocytes upon LPS challenge. To determine the function of sEH in podocytes in vivo we generated podocyte-specific sEH-deficient (pod-sEHKO) mice. Following LPS challenge, podocyte sEH-deficient mice exhibited lower kidney injury, proteinuria, and blood urea nitrogen concentrations than controls suggestive of preserved renal function. Also, renal mRNA and serum concentrations of inflammatory cytokines IL-6, IL-1β, and TNFα were significantly lower in LPS-treated pod-sEHKO than control mice. Moreover, podocyte sEH deficiency was associated with decreased LPS-induced NF-κB and MAPK activation and attenuated endoplasmic reticulum stress. Furthermore, the protective effects of podocyte sEH deficiency in vivo were recapitulated in E11 murine podocytes treated with a selective sEH pharmacological inhibitor. Altogether, these findings identify sEH in podocytes as a contributor to signaling events in acute renal injury and suggest that sEH inhibition may be of therapeutic value in proteinuria. Enzymes: Soluble epoxide hydrolase: EC 3.3.2.10.",
keywords = "knockout mice, podocyte, proteinuria, soluble epoxide hydrolase",
author = "Ahmed Bettaieb and Shinichiro Koike and Samah Chahed and Yi Zhao and Santana Bachaalany and Nader Hashoush and James Graham and Huma Fatima and Havel, {Peter J} and Artiom Gruzdev and Zeldin, {Darryl C.} and Hammock, {Bruce D.} and Fawaz Haj",
year = "2017",
month = "7",
day = "1",
doi = "10.1111/febs.14100",
language = "English (US)",
volume = "284",
pages = "1970--1986",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "13",

}

TY - JOUR

T1 - Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury

AU - Bettaieb, Ahmed

AU - Koike, Shinichiro

AU - Chahed, Samah

AU - Zhao, Yi

AU - Bachaalany, Santana

AU - Hashoush, Nader

AU - Graham, James

AU - Fatima, Huma

AU - Havel, Peter J

AU - Gruzdev, Artiom

AU - Zeldin, Darryl C.

AU - Hammock, Bruce D.

AU - Haj, Fawaz

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Podocytes play an important role in maintaining glomerular function, and podocyte injury is a significant component in the pathogenesis of proteinuria. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose genetic deficiency and pharmacological inhibition have beneficial effects on renal function, but its role in podocytes remains unexplored. The objective of this study was to investigate the contribution of sEH in podocytes to lipopolysaccharide (LPS)-induced kidney injury. We report increased sEH transcript and protein expression in murine podocytes upon LPS challenge. To determine the function of sEH in podocytes in vivo we generated podocyte-specific sEH-deficient (pod-sEHKO) mice. Following LPS challenge, podocyte sEH-deficient mice exhibited lower kidney injury, proteinuria, and blood urea nitrogen concentrations than controls suggestive of preserved renal function. Also, renal mRNA and serum concentrations of inflammatory cytokines IL-6, IL-1β, and TNFα were significantly lower in LPS-treated pod-sEHKO than control mice. Moreover, podocyte sEH deficiency was associated with decreased LPS-induced NF-κB and MAPK activation and attenuated endoplasmic reticulum stress. Furthermore, the protective effects of podocyte sEH deficiency in vivo were recapitulated in E11 murine podocytes treated with a selective sEH pharmacological inhibitor. Altogether, these findings identify sEH in podocytes as a contributor to signaling events in acute renal injury and suggest that sEH inhibition may be of therapeutic value in proteinuria. Enzymes: Soluble epoxide hydrolase: EC 3.3.2.10.

AB - Podocytes play an important role in maintaining glomerular function, and podocyte injury is a significant component in the pathogenesis of proteinuria. Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose genetic deficiency and pharmacological inhibition have beneficial effects on renal function, but its role in podocytes remains unexplored. The objective of this study was to investigate the contribution of sEH in podocytes to lipopolysaccharide (LPS)-induced kidney injury. We report increased sEH transcript and protein expression in murine podocytes upon LPS challenge. To determine the function of sEH in podocytes in vivo we generated podocyte-specific sEH-deficient (pod-sEHKO) mice. Following LPS challenge, podocyte sEH-deficient mice exhibited lower kidney injury, proteinuria, and blood urea nitrogen concentrations than controls suggestive of preserved renal function. Also, renal mRNA and serum concentrations of inflammatory cytokines IL-6, IL-1β, and TNFα were significantly lower in LPS-treated pod-sEHKO than control mice. Moreover, podocyte sEH deficiency was associated with decreased LPS-induced NF-κB and MAPK activation and attenuated endoplasmic reticulum stress. Furthermore, the protective effects of podocyte sEH deficiency in vivo were recapitulated in E11 murine podocytes treated with a selective sEH pharmacological inhibitor. Altogether, these findings identify sEH in podocytes as a contributor to signaling events in acute renal injury and suggest that sEH inhibition may be of therapeutic value in proteinuria. Enzymes: Soluble epoxide hydrolase: EC 3.3.2.10.

KW - knockout mice

KW - podocyte

KW - proteinuria

KW - soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=85019733569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019733569&partnerID=8YFLogxK

U2 - 10.1111/febs.14100

DO - 10.1111/febs.14100

M3 - Editorial

C2 - 28485854

AN - SCOPUS:85019733569

VL - 284

SP - 1970

EP - 1986

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 13

ER -